SIDP - FDA Advisory Committee recommends Isavuconazonium (Cresemba) for approval

FDA Advisory Committee recommends Isavuconazonium (Cresemba) for approval

13 Feb 2015 4:51 PM | Kristi Kuper

An advisory committee to the US Food and Drug Administration (FDA) voted unanimously to recommend isavuconazonium (ISA) (Cresemba, Astellas Pharma, Inc) for the treatment of adults with invasive aspergillosis (IA) and voted (8 yes, 2 no, 1 abstain) to recommend the drug for the treatment of adults with invasive mucormycosis (IM).http://www.medscape.com/viewarticle/838620